InvestorsHub Logo

GS1

Followers 115
Posts 4767
Boards Moderated 0
Alias Born 07/11/2010

GS1

Re: erg61 post# 19135

Sunday, 10/23/2016 1:08:22 PM

Sunday, October 23, 2016 1:08:22 PM

Post# of 34575
They sound reasonable to me and don't change their opinion based on share price moves. Example is ELTP. The stock went down due to FDA issuance of CRL but they remain bullish with right justification that other products hitting market and valuation will change. That is the kind of information you need as investor. One thing I agree is TPIV200 remains best in class based on Phase I data in their respective segment. i.e ovarian and TNBC.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News